Rheumatoid Arthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) It was in line with the diagnosis criteria of RA DAS28 > (2.6) of kidney deficiency and cold coagulation syndrome in Chinese medicine; (2) Aged 18-65 years, gender unlimited; (3) Those who voluntarily participate in the study and agree to sign the informed consent for entering the clinical study; (4) Doses were stable for at least 30 days before entry and remained constant for subsequent treatment in patients receiving NSAIDs and hormones. (5) Patients who voluntarily participate in the trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Severe joint deformity joint function in patients with late ? level, above symptom severity classification of severe patients. (2) Patients with other rheumatic diseases, such as systemic lupus erythematosus, Sjogren's syndrome, severe knee osteoarthritis, etc. (3) patients with heart, brain, liver, kidney, hematopoietic system and other serious primary diseases. (4) Pregnant or lactating women, mental patients. (5) Participating in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic Effect of TCM Diseases;TCM syndrome score;DAS28 score;Joint swelling number;Number of joint tenderness;HAQ;VAS score for the degree of pain assessed by the patient;The patient assessed the overall condition of the disease VAS score;The overall condition VAS score for the disease was assessed by the researchers;ESR;CRP;RF parting;CCP; | — |
Countries
China
Contacts
Yunnan Teaditional Chinese Medicine Hospital